Bone densitometry firm Norland Medical Systems of White Plains, NY, published its 1998 financial results this month, posting revenue for the fourth quarter (end-December) of $3.3 million, compared with $5.7 million in 1997. The net loss for the
Bone densitometry firm Norland Medical Systems of White Plains, NY, published its 1998 financial results this month, posting revenue for the fourth quarter (end-December) of $3.3 million, compared with $5.7 million in 1997. The net loss for the quarter was $4.3 million, compared with $2.8 million the previous year. The companys fiscal 1998 revenues fell to $14.4 million, down from 1997s $20.5 million. The net loss for the year was $9.7 million, compared with $18.6 million the year before.
The company attributed its decreased revenues to debt and unresolved litigation related to the acquisition of its manufacturing partner, Norland Corp. The distractions affected the companys sales efforts, according to Reynald Bonmati, chair and CEO. But on Dec. 31, the firm signed an agreement to settle the lawsuit, a move that contributed to the reduction of the companys debt by about 66%.
In other news, Norland also this month began shipping Excell DXA, an axial scanner that is the first table scanner in the U.S. listed below $30,000. The company introduced the unit at last years Radiological Society of North America meeting.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.